Suppr超能文献

来自SINUS - 24/-52研究的重度慢性鼻-鼻窦炎伴鼻息肉患者的鼻吸气峰流量及其与鼻阻塞的关系。

Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 Studies.

作者信息

Desrosiers Martin, Nash Scott, Lane Andrew, Lee Stella E, De Corso Eugenio, Xia Changming, Corbett Mark, Radwan Amr, Rowe Paul J, Deniz Yamo

机构信息

Division of Otolaryngology-Head and Neck Surgery, University of Montreal, Quebec, Canada.

Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.

出版信息

Adv Ther. 2025 Sep 27. doi: 10.1007/s12325-025-03378-2.

Abstract

INTRODUCTION

Nasal congestion/obstruction (NC) contributes to the high disease burden in patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP). Patient perception of NC may not accurately reflect nasal patency, while peak nasal inspiratory flow (PNIF) is an objective method with established thresholds for normal nasal airflow. This analysis evaluated the association between NC and PNIF and the impact of baseline PNIF on dupilumab efficacy in patients with severe CRSwNP.

METHODS

This was a post hoc analysis of patients treated with placebo or dupilumab 300 mg every 2 weeks in the SINUS-24 (NCT02912468) and SINUS-52 (NCT02898454) phase III studies. Patients provided daily e-diary measures of PNIF (L/min) using PNIF meters, and NC by patient-reported evaluation of severity (scored 0-3). Other assessed outcomes were nasal polyp score (NPS), 22-item Sinonasal Outcome Test (SNOT-22), loss of smell (LoS), University of Pennsylvania Smell Identification Test (UPSIT), and Lund-Mackay computed tomography. Outcomes were assessed in two subgroups: baseline PNIF < 120 L/min and ≥ 120 L/min.

RESULTS

Of 724 patients, 552 (76%) had PNIF < 120 L/min and 172 (24%) had PNIF ≥ 120 L/min at baseline. The PNIF < 120 L/min subgroup had higher mean scores for NPS and SNOT-22 and more smell impairment (LoS and UPSIT). PNIF weakly correlated with NC at baseline (Spearman coefficient - 0.348 [95% CI - 0.410, - 0.282], P < 0.0001). Correlations between change from baseline in PNIF and NC at week 24 were weak in the dupilumab group (- 0.390 [- 0.468, - 0.305], P < 0.0001) and moderate in the placebo group (- 0.497 [- 0.582, - 0.399], P < 0.0001).

CONCLUSION

These results confirm PNIF as a valuable method for assessing nasal obstruction in patients with severe CRSwNP. The degree of nasal flow impairment at baseline does not impact dupilumab's efficacy. A graphical abstract and video abstract are available for this article.

摘要

引言

鼻充血/鼻塞(NC)是导致重度慢性鼻-鼻窦炎伴鼻息肉(CRSwNP)患者疾病负担较重的原因之一。患者对NC的感知可能无法准确反映鼻腔通畅情况,而鼻吸气峰流速(PNIF)是一种客观方法,具有已确定的正常鼻气流阈值。本分析评估了NC与PNIF之间的关联以及基线PNIF对重度CRSwNP患者使用度普利尤单抗疗效的影响。

方法

这是一项对SINUS - 24(NCT02912468)和SINUS - 52(NCT02898454)两项III期研究中接受安慰剂或每2周一次300mg度普利尤单抗治疗的患者进行的事后分析。患者使用PNIF测量仪每日通过电子日记记录PNIF(升/分钟),并通过患者报告的严重程度评估记录NC(评分0 - 3)。其他评估的结局指标包括鼻息肉评分(NPS)、22项鼻鼻窦结局测试(SNOT - 22)、嗅觉减退(LoS)、宾夕法尼亚大学嗅觉识别测试(UPSIT)以及伦德 - 麦凯计算机断层扫描。结局指标在两个亚组中进行评估:基线PNIF<120升/分钟和≥120升/分钟。

结果

724例患者中,552例(76%)基线时PNIF<120升/分钟,172例(24%)基线时PNIF≥120升/分钟。PNIF<120升/分钟亚组的NPS和SNOT - 22平均得分更高,嗅觉损害(LoS和UPSIT)更严重。基线时PNIF与NC呈弱相关(斯皮尔曼系数 - 0.348 [95%CI - 0.410, - 0.282],P<0.0001)。度普利尤单抗组在第24周时PNIF相对于基线的变化与NC之间的相关性较弱( - 0.390 [- 0.468, - 0.305],P<0.0001),安慰剂组则为中度相关( - 0.497 [- 0.582, - 0.399],P<0.0001)。

结论

这些结果证实PNIF是评估重度CRSwNP患者鼻阻塞的一种有价值的方法。基线时鼻气流受损程度不影响度普利尤单抗的疗效。本文提供了图形摘要和视频摘要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验